A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to cutaneous and uveal melanoma patients.
García M, Moreno R, Gil-Martin M, Cascallò M, de Olza MO, Cuadra C, Piulats JM, Navarro V, Domenech M, Alemany R, Salazar R
HUMAN GENE THERAPY. (ISSN/ISBN: 10430342).
2019
Enhanced antitumor efficacy of oncolytic adenovirus-loaded menstrual blood-derived mesenchymal stem cells in combination with peripheral blood mononuclear cells
Moreno R, Fajardo CA, Farrera-Sal M, Perisé-Barrios AJ, Morales-Molina A, Al-Zaher AA, García-Castro J, Alemany R
MOLECULAR CANCER THERAPEUTICS. (ISSN/ISBN: 15357163).
2019
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1
Eriksson E, Milenova I, Wenthe J, Moreno R, Alemany R, Loskog A
JOURNAL OF IMMUNOLOGY. (ISSN/ISBN: 00221767).
2019
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer
Rovira-Rigau M, Raimondi G, Marín MÁ, Gironella M, Alemany R, Fillat C
MOLECULAR THERAPY. (ISSN/ISBN: 15250016).
2019
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
de Sostoa J, Fajardo CA, Moreno R, Ramos MD, Farrera-Sal M, Alemany R
JOURNAL FOR IMMUNOTHERAPY OF CANCER. (ISSN/ISBN: 20511426). 7(1): 19-19
2019
Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa G, Paco S, Vila-Ubach M, Cuadrado-Vilanova M, Castillo-Ecija H, Botteri G, Garcia-Gerique L, Moreno-Gilabert H, Gimenez-Alejandre M, Alonso-Lopez P, Farrera-Sal M, Torres-Manjon S, Ramos-Lozano D, Moreno R, Aerts I, Doz F, Cassoux N, Chapeaublanc E, Torrebadell M, Roldan M, König A, Suñol M, Claverol J, Lavarino C, Carmen de T, Fu L, Radvanyi F, Munier FL, Catalá-Mora J, Mora J, Alemany R, Cascalló M, Chantada GL, Carcaboso AM
SCIENCE TRANSLATIONAL MEDICINE. (ISSN/ISBN: 19466234). 11(476):
2019
Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers
Barlabé P, Sostoa J, Fajardo C, Alemany R, Moreno R
2019
Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus
Al-Zaher A., Moreno R., Fajardo C., Arias-Badia M., Farrera M., de Sostoa J., Rojas L., Alemany R.
MOLECULAR THERAPY - ONCOLYTICS (ISSN/ISBN: 23727705). 8 : 62-70
2018
Remission of spontaneous canine tumors after systemic cellular viroimmunotherapy.
Cejalvo T, Perisé-Barrios AJ, Del Portillo I, Laborda E, Rodriguez-Milla MA, Cubillo I, Vázquez F, Sardón D, Ramirez M, Alemany R, Del Castillo N, García-Castro J
CANCER RESEARCH. (ISSN/ISBN: 00085472).
2018
CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
Guedan, Sonia; Alemany, Ramon;
FRONTIERS IN IMMUNOLOGY (ISSN/ISBN: ). 9 (2460) : -
2018
See full list
1 
1 